@phdthesis{Scherer2003,
  author    = {Scherer, Stefan},
  title     = {Regulation und funktionelle Analyse der menschlichen Mismatchreparaturgene /-proteine am speziellen Beispiel von hMSH2},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-8317},
  school      = {Universit{\"a}t W{\"u}rzburg},
  year      = {2003},
  abstract  = {Das menschliche MHS2 Gen ist eine sehr gut charakterisierte Komponente des Mismatch-Reparatur-Systems (MMR) und h{\"a}ufig mit der HNPCC Erkrankung assoziiert. Der Mechanismus {\"u}ber den MSH2 an der Karzinomentwicklung beteiligt ist, sind Defekte in der DNA-Reparatur. Es konnte gezeigt werden, dass Mutationen in den kodierenden Regionen dieses Gens direkt in die Mikrosatelliteninstabilit{\"a}t involviert sind. Generell ist MSH2 ein Teil des postreplikativen Reparatursystems der Zellen, und sch{\"u}tzt so vor der Akkumulation von Mutationen. Dadurch wird die genetische Stabilit{\"a}t und Integrit{\"a}t gew{\"a}hrleistet. Ein anderer Teil der zellul{\"a}ren Krebsabwehr ist das p53 Tumorsuppressorgen. Ein m{\"o}glicher DNA Schaden, der in der Lage ist, p53 zu aktivieren, ist UV-Licht. Eine weitere gut charakterisierte Komponente der zellul{\"a}ren UV Reaktion ist der Transkriptionsfaktor c-Jun. Ziel der Arbeit war es die Regulation und Signalfunktion von MSH2 n{\"a}her zu charakterisieren. Dazu wurde der Promotor des Gens in ein Luziferase Promotorgenkonstrukt kloniert. Dieses Konstrukt wurde in menschliche Keratinozyten transfiziert, die nachfolgend mit UV bestrahlt wurden. Es konnte eine zeit- und dosisabh{\"a}ngige Hochregulation von MSH2 gezeigt werden. Diese Transkriptionserh{\"o}hung wurde von p53 initiiert, denn durch eine gezielte Mutation der p53-Bindungsstelle im MSH2 Promotor war dieser Effekt vollkommen aufgehoben. Interessanterweise war dieser Effekt von einem zus{\"a}tzlichen Faktor abh{\"a}ngig, ohne den keine Hochregulation erkennbar war. Verantwortlich hierf{\"u}r war der Transkriptionsfaktor c-Jun. Dadurch konnte eine funktionelle Interaktion von p53 und c-Jun in der transkriptionellen Aktivierung von hMSH2 gezeigt werden. Dieser zeit- und dosisabh{\"a}ngige Effekt war sowohl auf RNA als auch auf Proteinebene nachvollziehbar. Der gr{\"o}ßte Anstieg war bei 50 J/m2 zu verzeichnen, wohin gegen bei Verwendung von 75 J/m2 die Transkriptmenge geringer wurde, um bei 100 J/m2 erneut anzusteigen. Um diesen erneuten Anstieg des Proteins n{\"a}her zu beschreiben wurden bei den stark bestrahlten Zellen TUNEL-Untersuchungen durchgef{\"u}hrt. Hierbei zeigte sich eine positive Korrelation zwischen der Menge an MSH2 Protein und an TUNEL-positiven apoptotischen Zellen. Um weiter zu zeigen, dass der zweite Anstieg des Proteins nicht mit einer Reparaturfunktion verbunden ist, wurde ein biochemisch basierter Test durchgef{\"u}hrt, welcher die Reparaturkapazit{\"a}t semiquantitativ beschreibt. Dabei konnte klar gezeigt werden, dass die mit 100 J/m2 bestrahlten Zellen keine Reparaturfunktion mehr erf{\"u}llen. FACS-Analysen und Zellf{\"a}rbungen gegen Annexin V und mit Propidiumiodid best{\"a}tigten die stattfindende Apoptose in den Zellen. Eine weitere Komponente des MMR-Systems ist MSH6. MSH6 bildet mit MSH2 ein Dimer, welches den Fehler in der DNA erkennt und das weitere Reparaturprogramm einleitet. Die Expression dieses Proteins konnte nur bis zu einer Dosis von 50-75 J/m2 UV nachgewiesen werden. Im Gegensatz zu MSH2 war MSH6 nicht in 100 J/m2 bestrahlten Keratinozyten detektierbar. Um {\"u}ber die Lokalisation dieser Proteine mehr zu erfahren wurden Immunf{\"a}rbungen gegen MSH2 durchgef{\"u}hrt. Es zeigte sich eine Translokation des Proteins vom Kern in das Zytoplasma in Korrelation zum zunehmenden DNA-Schaden durch h{\"o}here Dosen an UV-Licht. Dies stellt eine m{\"o}gliche Verbindung zwischen dem Mismatch-Reparatursystem und apoptotischen Signalwegen dar.},
  subject      = {Mensch},
  language  = {de}
}
@phdthesis{Ulrich2012,
  author    = {Ulrich, Tanja},
  title     = {Function of Lin9 in vivo and MAP3K4-p38 signaling regulates p53 mediated cell cycle arrest after defective mitosis},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-73975},
  school      = {Universit{\"a}t W{\"u}rzburg},
  year      = {2012},
  abstract  = {Eine genaue Kontrolle des Verlaufs durch die Mitose ist entscheidend f{\"u}r die Gew{\"a}hrleistung genomischer Stabilit{\"a}t und f{\"u}r die Vermeidung von Aneuploidy. Der DREAM Komplex ist ein wichtiger Regulator der Expression von mitotischen Genen. Die Depletion der DREAM-Untereinheit Lin9, f{\"u}hrt zu einer verminderten Expression von G2/M Genen und beeintr{\"a}chtigt die Proliferation. In konditionellen knockout Mauszellen (MEFs) verursacht das Ausschalten von Lin9 Defekte in Mitose und Zytokinese und l{\"o}st vorzeitige Seneszenz aus, um eine weitere Zellproliferation zu verhindern. In dieser Arbeit konnte gezeigt werden, dass der seneszente Ph{\"a}notyp in Lin9 knockout MEFs unabh{\"a}ngig von den beiden Tumorsuppressor-Signalwegen p53-p21 und p16-pRB induziert wird. Untersuchungen mit dem konditionellen Lin9 knockout Mausmodell verdeutlichten die wichtige Funktion von Lin9 in der Regulierung der mitotischen Genexpression und der Proliferation in vivo. Das Fehlen von Lin9 f{\"u}hrte zu einer verringerten Proliferation in den Krypten des D{\"u}nndarms und verursachte eine Atrophie des Darmepithels und einen schnell eintretenden Tod der Tiere. Im zweiten Teil der Arbeit wurden Signalwege untersucht, die nach fehlerhafter Zytokinese zu einem p53 vermittelten G1-Arrest f{\"u}hren. Hierf{\"u}r wurde ein chemischer Inhibitor der mitotischen Kinase Aurora B verwendet. Mit Hilfe eines Hochdurchsatz siRNA Screens wurde die MAP Kinase MAP3K4 als Aktivator des p53 Signalwegs identifiziert. Es konnte gezeigt werden, dass MAP3K4 die Stresskinase p38b aktiviert, um den p53 vermittelten Zellzyklusarrest in tetraploiden Zellen auszul{\"o}sen. Dabei wurde p38b nach Hemmung von Aurora B f{\"u}r die transkriptionelle Aktivierung des p53 Zielgens p21 ben{\"o}tigt. Im Gegenteil dazu erfolgte die Phosphorylierung, Stabilisierung und die Rekrutierung von p53 an den p21 Promoter unabh{\"a}ngig von p38. Die teilweise Hemmung von Aurora B zeigte, dass fehlerhafte Segregation von Chromosomen auch den MAP3K4-p38-p53 Signalweg aktiviert und l{\"a}sst darauf schließen, dass subtile Defekte in der Mitose ausreichen diesen Stress-Signalweg zu induzieren. Obwohl p38 f{\"u}r den G1 Zellzyklusarrest nach mitotischen Sch{\"a}den erforderlich war, f{\"u}hrte die gleichzeitige Inhibierung von p38 und Aurora B {\"u}ber einen l{\"a}ngeren Zeitraum zu einer verringerten Proliferation, vermutlich aufgrund verst{\"a}rkter Apoptose. Es ist anzunehmen, dass der MAP3K4-p38-p53 Signalweg generell nach Defekten in der Mitose oder Zytokinese aktiviert wird um Zellen in G1 zu arretieren und um chromosomale Instabilit{\"a}t zu vermeiden.},
  subject      = {Mitose},
  language  = {en}
}
@article{ThiemHesbacherKneitzetal.2019,
  author    = {Thiem, Alexander and Hesbacher, Sonja and Kneitz, Hermann and di Primio, Teresa and Heppt, Markus V. and Hermanns, Heike M. and Goebeler, Matthias and Meierjohann, Svenja and Houben, Roland and Schrama, David},
  title     = {IFN-gamma-induced PD-L1 expression in melanoma depends on p53 expression},
  series = {Journal of Experimental \& Clinical Cancer Research},
  volume    = {38},
  journal   = {Journal of Experimental \& Clinical Cancer Research},
  doi       = {10.1186/s13046-019-1403-9},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-201016},
  pages     = {397},
  year      = {2019},
  abstract  = {Background Immune checkpoint inhibition and in particular anti-PD-1 immunotherapy have revolutionized the treatment of advanced melanoma. In this regard, higher tumoral PD-L1 protein (gene name: CD274) expression is associated with better clinical response and increased survival to anti-PD-1 therapy. Moreover, there is increasing evidence that tumor suppressor proteins are involved in immune regulation and are capable of modulating the expression of immune checkpoint proteins. Here, we determined the role of p53 protein (gene name: TP53) in the regulation of PD-L1 expression in melanoma. Methods We analyzed publicly available mRNA and protein expression data from the cancer genome/proteome atlas and performed immunohistochemistry on tumors with known TP53 status. Constitutive and IFN-ɣ-induced PD-L1 expression upon p53 knockdown in wildtype, TP53-mutated or JAK2-overexpressing melanoma cells or in cells, in which p53 was rendered transcriptionally inactive by CRISPR/Cas9, was determined by immunoblot or flow cytometry. Similarly, PD-L1 expression was investigated after overexpression of a transcriptionally-impaired p53 (L22Q, W23S) in TP53-wt or a TP53-knockout melanoma cell line. Immunoblot was applied to analyze the IFN-ɣ signaling pathway. Results For TP53-mutated tumors, an increased CD274 mRNA expression and a higher frequency of PD-L1 positivity was observed. Interestingly, positive correlations of IFNG mRNA and PD-L1 protein in both TP53-wt and -mutated samples and of p53 and PD-L1 protein suggest a non-transcriptional mode of action of p53. Indeed, cell line experiments revealed a diminished IFN-ɣ-induced PD-L1 expression upon p53 knockdown in both wildtype and TP53-mutated melanoma cells, which was not the case when p53 wildtype protein was rendered transcriptionally inactive or by ectopic expression of p53\(^{L22Q,W23S}\), a transcriptionally-impaired variant, in TP53-wt cells. Accordingly, expression of p53\(^{L22Q,W23S}\) in a TP53-knockout melanoma cell line boosted IFN-ɣ-induced PD-L1 expression. The impaired PD-L1-inducibility after p53 knockdown was associated with a reduced JAK2 expression in the cells and was almost abrogated by JAK2 overexpression. Conclusions While having only a small impact on basal PD-L1 expression, both wildtype and mutated p53 play an important positive role for IFN-ɣ-induced PD-L1 expression in melanoma cells by supporting JAK2 expression. Future studies should address, whether p53 expression levels might influence response to anti-PD-1 immunotherapy.},
  language  = {en}
}
@phdthesis{Kaymak2019,
  author    = {Kaymak, Irem},
  title     = {Identification of metabolic liabilities in 3D models of cancer},
  doi       = {10.25972/OPUS-18154},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-181544},
  school      = {Universit{\"a}t W{\"u}rzburg},
  year      = {2019},
  abstract  = {Inefficient vascularisation of solid tumours leads to the formation of oxygen and nutrient gradients. In order to mimic this specific feature of the tumour microenvironment, a multicellular tumour spheroid (SPH) culture system was used. These experiments were implemented in p53 isogenic colon cancer cell lines (HCT116 p53 +/+ and HCT116 p53-/-) since Tp53 has important regulatory functions in tumour metabolism. First, the characteristics of the cells cultured as monolayers and as spheroids were investigated by using RNA sequencing and metabolomics to compare gene expression and metabolic features of cells grown in different conditions. This analysis showed that certain features of gene expression found in tumours are also present in spheroids but not in monolayer cultures, including reduced proliferation and induction of hypoxia related genes. Moreover, comparison between the different genotypes revealed that the expression of genes involved in cholesterol homeostasis is induced in p53 deficient cells compared to p53 wild type cells and this difference was only detected in spheroids and tumour samples but not in monolayer cultures. In addition, it was established that loss of p53 leads to the induction of enzymes of the mevalonate pathway via activation of the transcription factor SREBP2, resulting in a metabolic rewiring that supports the generation of ubiquinone (coenzyme Q10). An adequate supply of ubiquinone was essential to support mitochondrial electron transport and pyrimidine biosynthesis in p53 deficient cancer cells under conditions of metabolic stress. Moreover, inhibition of the mevalonate pathway using statins selectively induced oxidative stress and apoptosis in p53 deficient colon cancer cells exposed to oxygen and nutrient deprivation. This was caused by ubiquinone being required for electron transfer by dihydroorotate dehydrogenase, an essential enzyme of the pyrimidine nucleotide biosynthesis pathway. Supplementation with exogenous nucleosides relieved the demand for electron transfer and restored viability of p53 deficient cancer cells under metabolic stress. Moreover, the mevalonate pathway was also essential for the synthesis of ubiquinone for nucleotide biosynthesis to support growth of intestinal tumour organoids. Together, these findings highlight the importance of the mevalonate pathway in cancer cells and provide molecular evidence for an enhanced sensitivity towards the inhibition of mitochondrial electron transfer in tumour-like metabolic environments.},
  subject      = {Tumor},
  language  = {en}
}
@article{DjuzenovaFiedlerMemmeletal.2019,
  author    = {Djuzenova, Cholpon S. and Fiedler, Vanessa and Memmel, Simon and Katzer, Astrid and Sisario, Dmitri and Brosch, Philippa K. and G{\"o}hrung, Alexander and Frister, Svenja and Zimmermann, Heiko and Flentje, Michael and Sukhorukov, Vladimir L.},
  title     = {Differential effects of the Akt inhibitor MK-2206 on migration and radiation sensitivity of glioblastoma cells},
  series = {BMC Cancer},
  volume    = {19},
  journal   = {BMC Cancer},
  doi       = {10.1186/s12885-019-5517-4},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-200290},
  pages     = {299},
  year      = {2019},
  abstract  = {Background Most tumor cells show aberrantly activated Akt which leads to increased cell survival and resistance to cancer radiotherapy. Therefore, targeting Akt can be a promising strategy for radiosensitization. Here, we explore the impact of the Akt inhibitor MK-2206 alone and in combination with the dual PI3K and mTOR inhibitor PI-103 on the radiation sensitivity of glioblastoma cells. In addition, we examine migration of drug-treated cells. Methods Using single-cell tracking and wound healing migration tests, colony-forming assay, Western blotting, flow cytometry and electrorotation we examined the effects of MK-2206 and PI-103 and/or irradiation on the migration, radiation sensitivity, expression of several marker proteins, DNA damage, cell cycle progression and the plasma membrane properties in two glioblastoma (DK-MG and SNB19) cell lines, previously shown to differ markedly in their migratory behavior and response to PI3K/mTOR inhibition. Results We found that MK-2206 strongly reduces the migration of DK-MG but only moderately reduces the migration of SNB19 cells. Surprisingly, MK-2206 did not cause radiosensitization, but even increased colony-forming ability after irradiation. Moreover, MK-2206 did not enhance the radiosensitizing effect of PI-103. The results appear to contradict the strong depletion of p-Akt in MK-2206-treated cells. Possible reasons for the radioresistance of MK-2206-treated cells could be unaltered or in case of SNB19 cells even increased levels of p-mTOR and p-S6, as compared to the reduced expression of these proteins in PI-103-treated samples. We also found that MK-2206 did not enhance IR-induced DNA damage, neither did it cause cell cycle distortion, nor apoptosis nor excessive autophagy. Conclusions Our study provides proof that MK-2206 can effectively inhibit the expression of Akt in two glioblastoma cell lines. However, due to an aberrant activation of mTOR in response to Akt inhibition in PTEN mutated cells, the therapeutic window needs to be carefully defined, or a combination of Akt and mTOR inhibitors should be considered.},
  language  = {en}
}
@article{PrietoGarciaTomaškovićShahetal.2021,
  author    = {Prieto-Garcia, Cristian and Tomašković, Ines and Shah, Varun Jayeshkumar and Dikic, Ivan and Diefenbacher, Markus},
  title     = {USP28: oncogene or tumor suppressor? a unifying paradigm for squamous cell carcinoma},
  series = {Cells},
  volume    = {10},
  journal   = {Cells},
  number    = {10},
  issn      = {2073-4409},
  doi       = {10.3390/cells10102652},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-248409},
  year      = {2021},
  abstract  = {Squamous cell carcinomas are therapeutically challenging tumor entities. Low response rates to radiotherapy and chemotherapy are commonly observed in squamous patients and, accordingly, the mortality rate is relatively high compared to other tumor entities. Recently, targeting USP28 has been emerged as a potential alternative to improve the therapeutic response and clinical outcomes of squamous patients. USP28 is a catalytically active deubiquitinase that governs a plethora of biological processes, including cellular proliferation, DNA damage repair, apoptosis and oncogenesis. In squamous cell carcinoma, USP28 is strongly expressed and stabilizes the essential squamous transcription factor ΔNp63, together with important oncogenic factors, such as NOTCH1, c-MYC and c-JUN. It is presumed that USP28 is an oncoprotein; however, recent data suggest that the deubiquitinase also has an antineoplastic effect regulating important tumor suppressor proteins, such as p53 and CHK2. In this review, we discuss: (1) The emerging role of USP28 in cancer. (2) The complexity and mutational landscape of squamous tumors. (3) The genetic alterations and cellular pathways that determine the function of USP28 in squamous cancer. (4) The development and current state of novel USP28 inhibitors.},
  language  = {en}
}
@article{DjuzenovaFischerKatzeretal.2021,
  author    = {Djuzenova, Cholpon S. and Fischer, Thomas and Katzer, Astrid and Sisario, Dmitri and Korsa, Tessa and Streussloff, Gudrun and Sukhorukov, Vladimir L. and Flentje, Michael},
  title     = {Opposite effects of the triple target (DNA-PK/PI3K/mTOR) inhibitor PI-103 on the radiation sensitivity of glioblastoma cell lines proficient and deficient in DNA-PKcs},
  series = {BMC Cancer},
  volume    = {21},
  journal   = {BMC Cancer},
  doi       = {10.1186/s12885-021-08930-1},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-265826},
  year      = {2021},
  abstract  = {Background: Radiotherapy is routinely used to combat glioblastoma (GBM). However, the treatment efficacy is often limited by the radioresistance of GBM cells. Methods: Two GBM lines MO59K and MO59J, differing in intrinsic radiosensitivity and mutational status of DNA-PK and ATM, were analyzed regarding their response to DNA-PK/PI3K/mTOR inhibition by PI-103 in combination with radiation. To this end we assessed colony-forming ability, induction and repair of DNA damage by gamma H2AX and 53BP1, expression of marker proteins, including those belonging to NHEJ and HR repair pathways, degree of apoptosis, autophagy, and cell cycle alterations. Results: We found that PI-103 radiosensitized MO59K cells but, surprisingly, it induced radiation resistance in MO59J cells. Treatment of MO59K cells with PI-103 lead to protraction of the DNA damage repair as compared to drug-free irradiated cells. In PI-103-treated and irradiated MO59J cells the foci numbers of both proteins was higher than in the drug-free samples, but a large portion of DNA damage was quickly repaired. Another cell line-specific difference includes diminished expression of p53 in MO59J cells, which was further reduced by PI-103. Additionally, PI-103-treated MO59K cells exhibited an increased expression of the apoptosis marker cleaved PARP and increased subG1 fraction. Moreover, irradiation induced a strong G2 arrest in MO59J cells (similar to 80\% vs. similar to 50\% in MO59K), which was, however, partially reduced in the presence of PI-103. In contrast, treatment with PI-103 increased the G2 fraction in irradiated MO59K cells. Conclusions: The triple-target inhibitor PI-103 exerted radiosensitization on MO59K cells, but, unexpectedly, caused radioresistance in the MO59J line, lacking DNA-PK. The difference is most likely due to low expression of the DNA-PK substrate p53 in MO59J cells, which was further reduced by PI-103. This led to less apoptosis as compared to drug-free MO59J cells and enhanced survival via partially abolished cell-cycle arrest. The findings suggest that the lack of DNA-PK-dependent NHEJ in MO59J line might be compensated by DNA-PK independent DSB repair via a yet unknown mechanism.},
  language  = {en}
}
@article{MainzSarhanRothetal.2022,
  author    = {Mainz, Laura and Sarhan, Mohamed A. F. E. and Roth, Sabine and Sauer, Ursula and Maurus, Katja and Hartmann, Elena M. and Seibert, Helen-Desiree and Rosenwald, Andreas and Diefenbacher, Markus E. and Rosenfeldt, Mathias T.},
  title     = {Autophagy blockage reduces the incidence of pancreatic ductal adenocarcinoma in the context of mutant Trp53},
  series = {Frontiers in Cell and Developmental Biology},
  volume    = {10},
  journal   = {Frontiers in Cell and Developmental Biology},
  issn      = {2296-634X},
  doi       = {10.3389/fcell.2022.785252},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-266005},
  year      = {2022},
  abstract  = {Macroautophagy (hereafter referred to as autophagy) is a homeostatic process that preserves cellular integrity. In mice, autophagy regulates pancreatic ductal adenocarcinoma (PDAC) development in a manner dependent on the status of the tumor suppressor gene Trp53. Studies published so far have investigated the impact of autophagy blockage in tumors arising from Trp53-hemizygous or -homozygous tissue. In contrast, in human PDACs the tumor suppressor gene TP53 is mutated rather than allelically lost, and TP53 mutants retain pathobiological functions that differ from complete allelic loss. In order to better represent the patient situation, we have investigated PDAC development in a well-characterized genetically engineered mouse model (GEMM) of PDAC with mutant Trp53 (Trp53\(^{R172H}\)) and deletion of the essential autophagy gene Atg7. Autophagy blockage reduced PDAC incidence but had no impact on survival time in the subset of animals that formed a tumor. In the absence of Atg7, non-tumor-bearing mice reached a similar age as animals with malignant disease. However, the architecture of autophagy-deficient, tumor-free pancreata was effaced, normal acinar tissue was largely replaced with low-grade pancreatic intraepithelial neoplasias (PanINs) and insulin expressing islet β-cells were reduced. Our data add further complexity to the interplay between Atg7 inhibition and Trp53 status in tumorigenesis.},
  language  = {en}
}